We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Recent Indian Swine Flu Isolates Display Mutations for Increased Virulence

By LabMedica International staff writers
Posted on 23 Mar 2015
Newly generated data regarding the H1N1 strain of swine flu that has killed more than 1,200 since December 2014 suggests that the virus has acquired mutations that make it more dangerous than previously circulating strains of H1N1 influenza.

Investigators at the Massachusetts Institute of Technology (Cambridge) compared the genetic sequences of two Indian swine flu strains that recently had been deposited into publicly available influenza databases to the strain of H1N1 that emerged in 2009 and killed more than 18,000 people worldwide between 2009 and 2012.

Image: Colorized transmission electron micrograph (TEM) showing H1N1 influenza virus particles (Photo courtesy of the [US] National Institute of Allergy and Infectious Diseases).
Image: Colorized transmission electron micrograph (TEM) showing H1N1 influenza virus particles (Photo courtesy of the [US] National Institute of Allergy and Infectious Diseases).

They found that that the recent Indian strains carried new mutations in the hemagglutinin protein (H1) that were known to be capable of increasing the virulence of the virus. One of the new mutations was in amino acid position D225, which had been linked with increased disease severity. Another mutation, in the T200A position, allowed hemagglutinin to bind more strongly to glycan receptors, making the virus more infectious.

These findings apparently contradict previous reports from Indian health officials that the strain had not diverged from the 2009 H1N1 version.

“We are really caught between a rock and a hard place, with little information and a lot of misinformation,” said senior author Dr. Ram Sasisekharan, professor of biological engineering at the Massachusetts Institute of Technology. “When you do real-time surveillance, get organized, and deposit these sequences, then you can come up with a better strategy to respond to the virus. The point we are trying to make is that there is a real need for aggressive surveillance to ensure that the anxiety and hysteria are brought down and people are able to focus on what they really need to worry about. We need to understand the pathology and the severity, rather than simply relying on anecdotal information. The goal is to get a clearer picture of the strains that are circulating and therefore anticipate the right kind of a vaccine strategy for 2016.”

The report was published in the March 11, 2015, issue of the journal Cell Host & Microbe.

Related Links:

Massachusetts Institute of Technology



Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Nuclear Matrix Protein 22 Test
NMP22 Test

Latest Microbiology News

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment